Department of the Army June 15, 2015 – Federal Register Recent Federal Regulation Documents
Results 1 - 2 of 2
Intent To Grant an Exclusive License for a U.S. Government-Owned Invention
In accordance with 35 U.S.C. 209(e), and 37 CFR 404.7(a)(1)(i), announcement is made of the intent to grant an exclusive, revocable license, to U.S. Provisional Patent No. 62/ 086,355, filed December 2, 2014, entitled, ``Novel Regimens of Tafenoquine For Prevention of Malaria in Malaria-Na[iuml]ve Subjects,'' U.S. Patent No. 6,479,660, issued November 12, 2002, entitled, ``Process for the Preparation of Anti-Malarial Drugs,'' and U.S. Patent No. 7,145,014, issued December 5, 2006, entitled ``Process for the Preparation of Quinoline Derivatives.'' The intended licensee is 60[deg] Pharmaceuticals, LLC, with its principal place of business at 1025 Connecticut Ave. NW., Suite 1000, Washington, DC 20036.
Proposed Collection; Comment Request
In compliance with the Paperwork Reduction Act of 1995, U.S. Army Public Health Command announces a proposed public information collection and seeks public comment on the provisions thereof. Comments are invited on: (a) Whether the proposed collection of information is necessary for the proper performance of the functions of the agency, including whether the information shall have practical utility; (b) the accuracy of the agency's estimate of the burden of the proposed information collection; (c) ways to enhance the quality, utility, and clarity of the information to be collected; and (d) ways to minimize the burden of the information collection on respondents, including through the use of automated collection techniques or other forms of information technology.
This site is protected by reCAPTCHA and the Google
Privacy Policy and
Terms of Service apply.
